Expo West 2026: Saanroo showcases delivery technology to improve ingredient bioavailability
19 Mar 2026 | Saanroo
At Natural Products Expo West 2026, Saanroo highlighted Trpti and BioBerb solutions, designed for metabolic health and weight management. John Quilter, CEO of the company, said that Trpti, a fatty acid that supports appetite suppression and microbiome health, has received positive feedback. Maggie McNamara, VP of Global Marketing, highlighted LipiSperse, the delivery technology developed by Pharmako Biotechnology that is used in both ingredients to improve bioavailability and enable incorporation into new formats. The experts said they expect new innovations in different formats, more similar to food and beverages.
This is Yolanda van Gaal from Nutrition Insight.
I'm here at Expo West 2026 with Maggie McNamara and John Wilder from Saro.
Thank you both for joining us, today.
And I'd love to hear because I know you're showcasing lots of different things here, and I'd love to talk about Tripti and Boburp, because I know you're showcasing this year.
What makes these ingredients uniquely effective compared with others in metabolic health and weight management?
Hi Yolanda, thank you for meeting with us today.
I hope you're having a great show.
Yes, Sorypty, , it's an interesting brand name that we just launched at the end of last year.
Trypty comes from the, Sanskrit word meaning, satiation or satiety or contentment.
And, we launched it, , at the expo last year and it's been a super exciting for us because it, it plays into, it's a, it's a fatty acid which plays into natural appetite suppression.
We, we've got a lot of good feedback from the industry, in particular, the practitioner, channel, on Tripty.
And just before the start of the show, we have, published a microbiome study which shows that, , Trypty supports the growth of beneficial bacteria, including acromansia, and there's a lot more being learned about acromansia in the industry in recent years.
It's a relatively low dosage.
You consume it about half an hour, 30 minutes before a meal.
And I know even some of my colleagues have been using it and giving it, it's in a tablet, it can be used in a tablet format in a ready to make beverage format.
It offers formulators a lot of opportunity to innovate in, in this metabolic health space.
Awesome, thank you and I'm also curious how do these ingredients perform across different product formats and what kinds of applications or products are brands most interested in when exploring with these ingredients?
OK, thanks for having us again, Yolanda, we appreciate your time here today we have a very unique delivery system in.
Both of these ingredients.
Lipispruce developed by Pharmaco Biotechnologies, they, this delivery technology makes these two ingredients very easy to work with in different formats because it increases their bioavailability and it allows them to be incorporated into formats that aren't normally.
For example, berberine and OEA, which is strep D basically, these are both traditionally been incorporated in a pill format.
Because that increases their delivery, and the taste for both of these ingredients isn't great.
With lippy Spurs being applied to these ingredients, it increases the scope, it now basically delivers the ingredient to where it needs to be.
And it also allows us to incorporate it into ingredients that or formats that weren't available before, for example, sachets, you know, there's right now, it's very, very, popular to have these morning GLP ones sort of help sachet things, trippty, for example, can now be included in a powder.
It'll increase the bioavailability of that ingredient because of the Lipisrus technology, and it is contributing to the society, obviously, Berberin, another one that, not only has a weird taste but causes, , digestive tract issues, with the lippy versus being delivered directly to where it needs to be, so it avoids and, and helps.
Avoid those distress, sort of GI tract distress issues, so it, it's very, it's very easy for it to be included into different formats that consumers want basically.
Awesome, interesting, and, At the same time, I understand that these are not ingredients that everyone knows on the market, but how do you think brands should communicate their benefits to consumers in a way that both builds the trust without oversimplifying science behind it?
So I like to talk about.
Brands not sort of selling those gimmicks sort of this is the, this is the the fat stopper or the burn your fat and that sort of language doesn't gel very with consumers anymore.
Consumers are very savvy, they understand, for example, bioavailability.
A few years ago, this was a term that the industry used, wasn't a term that consumers necessarily use, but consumers are more and more aware of the fact that it's not necessarily what you eat, it's what you absorb, right?
So I like to tell brands they need to bridge the gap between, Science and.
Explanation, they need to explain to the consumer that these ingredients, both fiber and trypty, mimic the body's natural responses.
With trypty, it's mimicking the GLP one, it OEA tells the brain that it needs to produce GLP one, so GLP one then tells us that we are full and it, it creates, it mimics that natural process that your body has.
Fioburb is the same thing, activate activates AMPK we all know that's the, that's the master metabolic regulator, right, so, It's bridging that gap between science and between what consumers can relate to.
They know AMPK, they know GLP-1, they kinda understand what it does, so it's just really explaining to them that these are things that your body already does.
These are not artificial things that are being.
Added to your body, these are just mimicking what your body does in natural processes.
So I think it's very important for brands to not try and sell hype, but to try and sell that explanation, bridge that science, that gap between science and understanding.
OK, yeah, awesome.
Another thing that we see.
And you see it here a lot as at the show, consumers are turning more towards functional foods and supplements to manage metabolic health.
How do you or what do you think is the next major disruption in this phase?
Very interesting, we're seeing a lot of.
In recent years, there was an explosion in gummies and obviously pill fatigue.
Now we're seeing the next explosion, which we see is liquid systems, systems that are closer to, be it shots, be it gels.
Basically supplements that are closer to food and beverage.
And there's an experiential, we're seeing it with earlier, younger consumers are coming to the category.
There are some, I would call it mega brands that are growing very quickly, in this category, and many of them are here, on display.
You don't have to look too far.
But the, the consumer is moving a lot more towards this liquid format.
As a new, as a new innovation in this, in this space, and that's not to discount gummies, but I think it's the next wave of innovation.
We'll look forward to that.
Thank you both so much.
Thank you, Alanda.
